Please login to the form below
Decibel Therapeutics
This page shows the latest Decibel Therapeutics news and features for those working in and with pharma, biotech and healthcare.
Regeneron to acquire Decibel Therapeutics in deal worth up to $213m
Regeneron Pharmaceuticals has entered into a definitive agreement to acquire hearing loss specialist Decibel Therapeutics in a deal worth as much as $213m. ... The agreement builds on the existing gene therapy collaboration between Regeneron and Decibel
Latest news
-
Biotech leaders jump into US free speech debate
Alnylam chief executive John Maraganore, Decibel Therapeutics’ CEO Steve Holtzman, Acorda CEO Ron Cohen and Jeremy Levin of Ovid Therapeutics are the main signatories to the letter published In Nature, but
More from news
Approximately 1 fully matching, plus 1 partially matching documents found.
Latest appointments
-
Decibel Therapeutics expands leadership team
Hearing disorders specialist Decibel Therapeutics has expanded its leadership team and board of directors with four new appointments. ... products. Steve Holtzman, president and chief executive of Decibel Therapeutics, said: “We are thrilled to welcome
-
Decibel Therapeutics appoints former Biogen exec as president and CEO
Steven Holtzman succeeds interim CEO Kevin Starr. Decibel Therapeutics has appointed Steven Holtzman as its new president and chief executive officer, succeeding interim chief executive Kevin Starr.
More from appointments
Approximately 2 fully matching, plus 0 partially matching documents found.
Subscribe to our email news alerts
- AstraZeneca and Daiichi Sankyo share positive results from phase 3 breast cancer study
- ICR and Merck renew strategic alliance for development of new cancer drugs
- DeepMind’s AI tool classifies effects of mutations in genetic diseases
- CDC awards over $23m to Johns Hopkins Center for Health Security project
- Looking to start activity on a currently unpromoted pharmaceutical brand?
- Considering a portfolio review?
No results were found
PMHub
nzyme
The nzyme group focuses on the three fundamentals that enable full patient access - Education, Access & Activation. Our specialist...
Latest intelligence
- The importance of accelerating clinical trial diversity
- Diversity shouldn’t be an afterthought – it’s an investment in the credibility of scientific endeavour...
- Digital Opinion Leaders: The Role of Influencers in Medical Communications
- There are many informed, knowledgeable HCPs who talk about a disease state online, but not all of them are influencers. This paper explores who digital opinion leaders are and how...
- Creating Hope Though Action – World Suicide Prevention Day
- At Mednet Group, we believe that actions speak louder than words. That's why we're getting behind this year's Suicide Prevention Day campaign of 'creating hope through action'....
